Works matching AU Arkenau, Hendrik-Tobias

Results: 60
    1

    Enumeration and Molecular Characterisation of Circulating Tumour Cells in Endometrial Cancer.

    Published in:
    Oncology, 2016, v. 91, n. 1, p. 48, doi. 10.1159/000445999
    By:
    • Lemech, Charlotte R.;
    • Ensell, Leah;
    • Paterson, Jennifer C.;
    • Eminowicz, Gemma;
    • Lowe, Helen;
    • arora, Rupali;
    • arkenau, Hendrik-Tobias;
    • Widschwendter, Martin;
    • MacDonald, Nicola;
    • Olaitan, adeola;
    • Mould, Tim;
    • Meyer, Tim;
    • Hartley, John;
    • Mitra, anita;
    • Ledermann, Jonathan a.;
    • McCormack, Mary;
    • Kristeleit, Rebecca S.
    Publication type:
    Article
    2
    3
    4
    5
    6
    7

    Pharmacokinetic Interaction Between the MEK1/MEK2 Inhibitor Trametinib and Oral Contraceptives Containing Norethindrone and Ethinyl Estradiol in Female Patients With Solid Tumors.

    Published in:
    Clinical Pharmacology in Drug Development, 2022, v. 11, n. 5, p. 585, doi. 10.1002/cpdd.1052
    By:
    • Arkenau, Hendrik‐Tobias;
    • Taylor, Donatienne;
    • Xu, Xiaoying;
    • Chitnis, Shripad;
    • Llacer‐Perez, Casilda;
    • Moore, Kathleen;
    • Nidamarthy, Prasanna Kumar;
    • Ilankumaran, Palanichamy;
    • De Vos‐Geelen, Judith
    Publication type:
    Article
    8

    Complexity of FGFR signalling in metastatic urothelial cancer.

    Published in:
    Journal of Hematology & Oncology, 2015, v. 8, p. 1, doi. 10.1186/s13045-015-0221-6
    By:
    • Rodriguez-Vida, Alejo;
    • Saggese, Matilde;
    • Hughes, Simon;
    • Rudman, Sarah;
    • Chowdhury, Simon;
    • Smith, Neil R.;
    • Lawrence, Peter;
    • Rooney, Claire;
    • Dougherty, Brian;
    • Landers, Donal;
    • Kilgour, Elaine;
    • Arkenau, Hendrik-Tobias
    Publication type:
    Article
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21

    Phase 1b study of berzosertib and cisplatin in patients with advanced triple-negative breast cancer.

    Published in:
    NPJ Breast Cancer, 2022, v. 8, n. 1, p. 1, doi. 10.1038/s41523-022-00406-0
    By:
    • Telli, Melinda L.;
    • Tolaney, Sara M.;
    • Shapiro, Geoffrey I.;
    • Middleton, Mark;
    • Lord, Simon R.;
    • Arkenau, Hendrik Tobias;
    • Tutt, Andrew;
    • Abramson, Vandana;
    • Dean, Emma;
    • Haddad, Tufia C.;
    • Wesolowski, Robert;
    • Ferrer-Playan, Jordi;
    • Goddemeier, Thomas;
    • Grombacher, Thomas;
    • Dong, Jennifer;
    • Fleuranceau-Morel, Patricia;
    • Diaz-Padilla, Ivan;
    • Plummer, Ruth
    Publication type:
    Article
    22
    23

    Evaluation of the effect of dabrafenib and metabolites on QTc interval in patients with <italic>BRAF</italic> V600–mutant tumours.

    Published in:
    British Journal of Clinical Pharmacology, 2018, v. 84, n. 4, p. 764, doi. 10.1111/bcp.13488
    By:
    • Nebot, Noelia;
    • Arkenau, Hendrik‐Tobias;
    • Infante, Jeffrey R.;
    • Chandler, Jason C.;
    • Weickhardt, Andrew;
    • Lickliter, Jason D.;
    • Sarantopoulos, John;
    • Gordon, Michael S.;
    • Mak, Gabriel;
    • St‐Pierre, Annie;
    • Tang, Lihua;
    • Mookerjee, Bijoyesh;
    • Carson, Stanley W.;
    • Hayes, Siobhan;
    • Grossmann, Kenneth F.
    Publication type:
    Article
    24
    25
    26

    Avelumab, an anti-PD-L1 antibody, in patients with locally advanced or metastatic breast cancer: a phase 1b JAVELIN Solid Tumor study.

    Published in:
    Breast Cancer Research & Treatment, 2018, v. 167, n. 3, p. 671, doi. 10.1007/s10549-017-4537-5
    By:
    • Dirix, Luc Y.;
    • Takacs, Istvan;
    • Jerusalem, Guy;
    • Nikolinakos, Petros;
    • Arkenau, Hendrik-Tobias;
    • Forero-Torres, Andres;
    • Boccia, Ralph;
    • Lippman, Marc E.;
    • Somer, Robert;
    • Smakal, Martin;
    • Emens, Leisha A.;
    • Hrinczenko, Borys;
    • Edenfield, William;
    • Gurtler, Jayne;
    • von Heydebreck, Anja;
    • Grote, Hans Juergen;
    • Chin, Kevin;
    • Hamilton, Erika P.
    Publication type:
    Article
    27
    28
    29

    Ramucirumab in Combination with Pembrolizumab in Treatment-Naïve Advanced Gastric or GEJ Adenocarcinoma: Safety and Antitumor Activity from the Phase 1a/b JVDF Trial.

    Published in:
    Cancers, 2020, v. 12, n. 10, p. 2985, doi. 10.3390/cancers12102985
    By:
    • Chau, Ian;
    • Penel, Nicolas;
    • Soriano, Andres O.;
    • Arkenau, Hendrik-Tobias;
    • Cultrera, Jennifer;
    • Santana-Davila, Rafael;
    • Calvo, Emiliano;
    • Le Tourneau, Christophe;
    • Zender, Lars;
    • Bendell, Johanna C.;
    • Mi, Gu;
    • Gao, Ling;
    • McNeely, Samuel Clark;
    • Oliveira, Joana M.;
    • Ferry, David;
    • Herbst, Roy S.;
    • Fuchs, Charles S.
    Publication type:
    Article
    30
    31
    32
    33
    34
    35
    36

    Phase I study of continuous olaparib capsule dosing in combination with carboplatin and/or paclitaxel (Part 1).

    Published in:
    Investigational New Drugs, 2020, v. 38, n. 4, p. 1117, doi. 10.1007/s10637-019-00856-7
    By:
    • van der Noll, Ruud;
    • Jager, Agnes;
    • Ang, Joo Ern;
    • Marchetti, Serena;
    • Mergui-Roelvink, Marja W. J.;
    • Lolkema, Martijn P.;
    • de Jonge, Maja J. A.;
    • van der Biessen, Diane A.;
    • Brunetto, Andre T.;
    • Arkenau, Hendrik-Tobias;
    • Tchakov, Ilian;
    • Beijnen, Jos H.;
    • de Bono, Johann S.;
    • Schellens, Jan H. M.
    Publication type:
    Article
    37

    Phase I study of intermittent olaparib capsule or tablet dosing in combination with carboplatin and paclitaxel (part 2).

    Published in:
    Investigational New Drugs, 2020, v. 38, n. 4, p. 1096, doi. 10.1007/s10637-019-00857-6
    By:
    • van der Noll, Ruud;
    • Jager, Agnes;
    • Ang, Joo Ern;
    • Marchetti, Serena;
    • Mergui-Roelvink, Marja W. J.;
    • de Bono, Johann S.;
    • Lolkema, Martijn P.;
    • de Jonge, Maja J. A.;
    • van der Biessen, Diane A.;
    • Brunetto, Andre T.;
    • Arkenau, Hendrik-Tobias;
    • Tchakov, Ilian;
    • Beijnen, Jos H.;
    • De Grève, Jacques;
    • Schellens, Jan H. M.
    Publication type:
    Article
    38
    39

    Phase 1b study to assess the safety, tolerability, and clinical activity of pamiparib in combination with temozolomide in patients with locally advanced or metastatic solid tumors.

    Published in:
    Cancer Medicine, 2024, v. 13, n. 13, p. 1, doi. 10.1002/cam4.7385
    By:
    • Stradella, Agostina;
    • Johnson, Melissa;
    • Goel, Sanjay;
    • Park, Haeseong;
    • Lakhani, Nehal;
    • Arkenau, Hendrik‐Tobias;
    • Galsky, Matthew D.;
    • Calvo, Emiliano;
    • Baz, Vicente;
    • Moreno, Victor;
    • Saavedra, Omar;
    • Luen, Stephen J.;
    • Mu, Song;
    • Wan, Qiting;
    • Chang, Victoria;
    • Zhang, Wa;
    • Barve, Minal
    Publication type:
    Article
    40
    41

    HIF2α, Hepcidin and their crosstalk as tumour-promoting signalling.

    Published in:
    British Journal of Cancer, 2023, v. 129, n. 2, p. 222, doi. 10.1038/s41416-023-02266-2
    By:
    • Formica, Vincenzo;
    • Riondino, Silvia;
    • Morelli, Cristina;
    • Guerriero, Simona;
    • D'Amore, Federica;
    • Di Grazia, Antonio;
    • Del Vecchio Blanco, Giovanna;
    • Sica, Giuseppe;
    • Arkenau, Hendrik-Tobias;
    • Monteleone, Giovanni;
    • Roselli, Mario
    Publication type:
    Article
    42

    Trifluridine/tipiracil in patients with metastatic gastroesophageal junction cancer: a subgroup analysis from the phase 3 TAGS study.

    Published in:
    Gastric Cancer, 2021, v. 24, n. 4, p. 970, doi. 10.1007/s10120-021-01156-x
    By:
    • Mansoor, Wasat;
    • Arkenau, Hendrik-Tobias;
    • Alsina, Maria;
    • Shitara, Kohei;
    • Thuss-Patience, Peter;
    • Cuffe, Sinead;
    • Dvorkin, Mikhail;
    • Park, David;
    • Ando, Takayuki;
    • Van Den Eynde, Marc;
    • Beretta, Giordano D.;
    • Zaniboni, Alberto;
    • Doi, Toshihiko;
    • Tabernero, Josep;
    • Ilson, David H.;
    • Makris, Lukas;
    • Benhadji, Karim A.;
    • Van Cutsem, Eric
    Publication type:
    Article
    43

    Health-related quality of life associated with trifluridine/tipiracil in heavily pretreated metastatic gastric cancer: results from TAGS.

    Published in:
    Gastric Cancer, 2020, v. 23, n. 4, p. 689, doi. 10.1007/s10120-020-01053-9
    By:
    • Tabernero, Josep;
    • Alsina, Maria;
    • Shitara, Kohei;
    • Doi, Toshihiko;
    • Dvorkin, Mikhail;
    • Mansoor, Wasat;
    • Arkenau, Hendrik-Tobias;
    • Prokharau, Aliaksandr;
    • Ghidini, Michele;
    • Faustino, Catia;
    • Gorbunova, Vera;
    • Zhavrid, Edvard;
    • Nishikawa, Kazuhiro;
    • Ando, Takayuki;
    • Yalçın, Şuayib;
    • Van Cutsem, Eric;
    • Sabater, Javier;
    • Skanji, Donia;
    • Leger, Catherine;
    • Amellal, Nadia
    Publication type:
    Article
    44
    45
    46
    47

    Untailored vs. Gender- and Body-Mass-Index-Tailored Skeletal Muscle Mass Index (SMI) to Assess Sarcopenia in Advanced Head and Neck Squamous Cell Carcinoma (HNSCC).

    Published in:
    Cancers, 2023, v. 15, n. 19, p. 4716, doi. 10.3390/cancers15194716
    By:
    • Morelli, Cristina;
    • Formica, Vincenzo;
    • Bossi, Paolo;
    • Rofei, Michela;
    • Guerriero, Simona;
    • Riondino, Silvia;
    • Argirò, Renato;
    • Pucci, Noemi;
    • Cenci, Tonia;
    • Savino, Luca;
    • Rinaldi, Carla G.;
    • Garaci, Francesco;
    • Orlandi, Augusto;
    • D'Angelillo, Rolando M.;
    • Arkenau, Hendrik-Tobias;
    • Roselli, Mario
    Publication type:
    Article
    48

    Irinotecan- vs. Oxaliplatin-Based Doublets in KRAS G12C -Mutated Metastatic Colorectal Cancer—A Multicentre Propensity-Score-Matched Retrospective Analysis.

    Published in:
    Cancers, 2023, v. 15, n. 11, p. 3064, doi. 10.3390/cancers15113064
    By:
    • Formica, Vincenzo;
    • Morelli, Cristina;
    • Conca, Veronica;
    • Calegari, Maria Alessandra;
    • Lucchetti, Jessica;
    • Dell'Aquila, Emanuela;
    • Schirripa, Marta;
    • Messina, Marco;
    • Salvatore, Lisa;
    • Lo Prinzi, Federica;
    • Dima, Giovanni;
    • Trovato, Giovanni;
    • Riondino, Silvia;
    • Roselli, Mario;
    • Skoulidis, Ferdinandos;
    • Arkenau, Hendrik-Tobias;
    • Cremolini, Chiara
    Publication type:
    Article
    49

    Results from a Phase 1b/2 Study of Ibrutinib Combination Therapy in Advanced Urothelial Carcinoma.

    Published in:
    Cancers, 2023, v. 15, n. 11, p. 2978, doi. 10.3390/cancers15112978
    By:
    • Mar, Nataliya;
    • Zakharia, Yousef;
    • Falcon, Alejandro;
    • Morales-Barrera, Rafael;
    • Mellado, Begona;
    • Duran, Ignacio;
    • Oh, Do-Youn;
    • Williamson, Stephen K.;
    • Gajate, Pablo;
    • Arkenau, Hendrik-Tobias;
    • Jones, Robert J.;
    • Teo, Min Yuen;
    • Turan, Tolga;
    • McLaughlin, Robert T.;
    • Peltier, Hillary M.;
    • Chong, Elizabeth;
    • Atluri, Harisha;
    • Dean, James P.;
    • Castellano, Daniel
    Publication type:
    Article
    50